Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

Following publication of the original article

Bibliographic Details
Main Authors:	Daniel Schöttle, Wolfgang Janetzky, Daniel Luedecke, Elmar Beck, Christoph U. Correll, Klaus Wiedemann
Format:	Article
Language:	English
Published:	BMC 2018-12-01
Series:	BMC Psychiatry
Online Access:	http://link.springer.com/article/10.1186/s12888-018-1968-4

Similar Items

Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
by: Daniel Schöttle, et al.
Published: (2018-11-01)

The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index
by: Daniel Schöttle, et al.
Published: (2020-02-01)

Schizophrenia relapse and the clinical usefulness of once-monthly aripiprazole depot injection
by: Wang SM, et al.
Published: (2014-08-01)

The effect of switching from oral low-dose aripiprazole to aripiprazole once-monthly 300 mg on the quality of life in three patients with schizophrenia
by: Hidenobu Suzuki, et al.
Published: (2017-05-01)

Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia
by: Michele Wilson, et al.
Published: (2016-03-01)

Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
by: De Hert M, et al.
Published: (2015-05-01)

Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
by: Oya K, et al.
Published: (2015-09-01)

Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies
by: Madera JJ, et al.
Published: (2019-06-01)

The clinical utility of serum level of Aripiprazole and Dehydro-aripiprazole in schizophrenia
by: Hui-Hsin Chuang, et al.
Published: (2016)

Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis
by: Christophe Sapin, et al.
Published: (2016-09-01)

Aripiprazole for late-life schizophrenia
by: Jeffrey Rado, et al.
Published: (2010-08-01)

Review of depot aripiprazole for schizophrenia
by: Motiwala FB, et al.
Published: (2013-11-01)

Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study
by: Nestor Szerman, et al.
Published: (2020-02-01)

Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
by: Steven G Potkin, et al.
Published: (2017-01-01)

The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies
by: Peters-Strickland T, et al.
Published: (2019-06-01)

Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study
by: Nestor Szerman, et al.
Published: (2020-02-01)

Correction: Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study.
by: PLOS ONE Staff
Published: (2017-01-01)

Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study
by: Joseph R. Calabrese, et al.
Published: (2018-06-01)

Role of aripiprazole in treatment-resistant schizophrenia
by: Mossaheb N, et al.
Published: (2012-05-01)

Spotlight on once-monthly long-acting injectable aripiprazole and its potential as maintenance treatment for bipolar I disorder in adult patients
by: Torres-Llenza V, et al.
Published: (2018-01-01)

Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia.
by: Zhenhe Zhou, et al.
Published: (2013-01-01)

Aripiprazole-associated tic in a schizophrenia patient
by: Guo X, et al.
Published: (2015-03-01)

Real-life assessment of aripiprazole monthly (Abilify Maintena) in schizophrenia: a Canadian naturalistic non-interventional prospective cohort study
by: Sally Mustafa, et al.
Published: (2019-04-01)

Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting
by: Hodgson RE
Published: (2019-08-01)

Aripiprazol e síndrome de Tourette Aripiprazole and Tourette syndrome
by: Ana Hounie, et al.
Published: (2004-09-01)

The safety and tolerability of aripiprazole once-monthly as maintenance treatment for bipolar I disorder: A double-blind, placebo-controlled, randomized withdrawal study
by: Amatniek, J., et al.
Published: (2018)

Evaluating the cost and clinical effectiveness of long-acting, injectable aripiprazole and paliperidone palmitate once a month in a real-world setting [Corrigendum]
by: Hodgson RE
Published: (2019-09-01)

Effect of aripiprazole and olanzapine on the cognitive function in patients with schizophrenia
by: Xiao-Hong Wang
Published: (2020-05-01)

Aripiprazole for refractory catatonic schizophrenia – A case report
by: Saisudha N V Gorthi, et al.
Published: (2015-01-01)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
by: Sasaki Tsuyoshi, et al.
Published: (2012-05-01)

The Solubility of Aripiprazole with Cyclodextrin
by: Lai-Cheng Chin, et al.
Published: (2013)

Aripiprazole-induced priapism
by: Satya K Trivedi, et al.
Published: (2016-01-01)

Aripiprazole cardiosafety: Is it overestimated?
by: Ahmed Naguy
Published: (2016-01-01)

Mania/hipomania induzida por aripiprazol Manic/hypomanic symptoms induced by aripiprazole
by: Márcio Gerhardt Soeiro de Souza, et al.
Published: (2010-01-01)

A Case of Hypersexuality in a Patient Receiving Aripiprazole for Schizophrenia
by: Lakshmi Priya, et al.
Published: (2021-01-01)

Cognitive Impairment in Schizophrenia, Neurotransmitters and the New Atypical Antipsychotic Aripiprazole
by: Topolov Mariyan K., et al.
Published: (2016-03-01)

Use of Aripiprazole Long Acting Injection in Negative Symptoms of Schizophrenia
by: Suneeta James, et al.
Published: (2016-01-01)

Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice
by: Nobue Kitanaka, et al.
Published: (2015-01-01)

Pretreatment or Posttreatment with Aripiprazole Attenuates Methamphetamine-induced Stereotyped Behavior in Mice
by: Nobue Kitanaka, et al.
Published: (2015-09-01)

Cost/effectiveness of aripiprazole vs. olanzapine in the long-term treatment of schizophrenia
by: Dutina Aleksandra, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_0kgurimveb6a6t0egh9ef2taer